Anavex Life Sciences (AVXL) Share-based Compensation Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | -46.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46.13% |
| Sep 30, 2025 | 4.48% |
| Jun 30, 2025 | -41.57% |
| Mar 31, 2025 | -45.36% |
| Dec 31, 2024 | -10.10% |
| Sep 30, 2024 | 115.67% |
| Jun 30, 2024 | 91.41% |
| Mar 31, 2024 | -33.20% |
| Dec 31, 2023 | -57.25% |
| Sep 30, 2023 | -46.94% |
| Jun 30, 2023 | -3.07% |
| Mar 31, 2023 | -10.57% |
| Dec 31, 2022 | 36.79% |
| Sep 30, 2022 | 94.29% |
| Jun 30, 2022 | 73.88% |
| Mar 31, 2022 | 140.47% |
| Dec 31, 2021 | 316.13% |
| Sep 30, 2021 | 372.39% |
| Jun 30, 2021 | 83.35% |
| Mar 31, 2021 | 8.55% |
| Dec 31, 2020 | -25.71% |
| Sep 30, 2020 | -46.58% |
| Jun 30, 2020 | 1.37% |
| Mar 31, 2020 | -10.16% |
| Dec 31, 2019 | -38.83% |
| Sep 30, 2019 | -17.10% |
| Jun 30, 2019 | -26.44% |
| Mar 31, 2019 | 54.46% |
| Dec 31, 2018 | 84.23% |
| Sep 30, 2018 | 33.45% |
| Jun 30, 2018 | 44.67% |
| Mar 31, 2018 | 26.50% |
| Dec 31, 2017 | 26.17% |
| Sep 30, 2017 | -70.47% |
| Jun 30, 2017 | 403.70% |
| Mar 31, 2017 | 335.09% |
| Dec 31, 2016 | 7.66% |
| Sep 30, 2016 | 176.60% |
| Jun 30, 2016 | 1,940.58% |
| Dec 31, 2015 | 5,277.03% |
| Sep 30, 2015 | 117.80% |
| Jun 30, 2015 | 17.67% |
| Sep 30, 2014 | -37.32% |
| Jun 30, 2012 | -37.93% |
| Mar 31, 2012 | -88.01% |
| Dec 31, 2011 | -34.35% |
| Sep 30, 2011 | 76.64% |